Which has grown faster, ABUS or QDEL?

Over the past five years, ABUS grew revenue faster — ABUS at a 85.17% CAGR versus QDEL at 7.14%.

Is ABUS or QDEL more profitable?

ABUS runs the higher net margin — ABUS at 84.23% versus QDEL at -39.20%.

How have ABUS and QDEL total returns compared?

Over the past 10 years, ABUS delivered 2.93% and QDEL delivered -5.68% annualized total return. Past performance doesn't predict future results.

Arbutus Biopharma Corp (ABUS) vs QuidelOrtho Corporation (QDEL)

A side-by-side comparison of Arbutus Biopharma Corp and QuidelOrtho Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABUS

Arbutus Biopharma Corp

$884M

$4.47HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

QDEL

QuidelOrtho Corporation

$841M

$12.33HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

Total return — ABUS vs QDEL

growth of $100 · dividends reinvested · last 10y

ABUS +45.9% (+3.9%/yr)QDEL -43.9% (-5.6%/yr)ABUS compounded faster over this window

ABUS QDEL

ABUS vs QDEL: by the numbers

•ABUS is the larger company ($884M vs $841M market cap).
•ABUS is profitable (84.23% net margin) while QDEL runs a net loss (-39.20%).
•ABUS grew revenue faster over the past five years (85.17% vs 7.14% CAGR).

Metrics side by side

Valuation

Metric	ABUS	QDEL
P/E ratio	5.73	N/A
Forward P/E	6.05	15.96
P/S ratio	4.86	0.31
P/B ratio	3.42	0.47
EV / EBITDA	5.90	N/A

Profitability

Metric	ABUS	QDEL
Gross margin	99.98%	44.60%
Operating margin	-192.08%	-30.67%
Net margin	84.23%	-39.20%
ROE	59.16%	-59.07%
ROIC	54.39%	-16.05%

Growth (annualized)

Metric	ABUS	QDEL
Revenue CAGR (5Y)	85.17%	7.14%
Total return CAGR (5Y)	2.19%	-38.12%

Frequently asked

Which has grown faster, ABUS or QDEL?: Over the past five years, ABUS grew revenue faster — ABUS at a 85.17% CAGR versus QDEL at 7.14%.
Is ABUS or QDEL more profitable?: ABUS runs the higher net margin — ABUS at 84.23% versus QDEL at -39.20%.
How have ABUS and QDEL total returns compared?: Over the past 10 years, ABUS delivered 2.93% and QDEL delivered -5.68% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABUS analysis Full QDEL analysis Interactive comparison tool

Dig into the metrics

Arbutus Biopharma P/E ratio Arbutus Biopharma ROE QuidelOrtho ROE Arbutus Biopharma operating margin QuidelOrtho operating margin Arbutus Biopharma revenue growth QuidelOrtho revenue growth Arbutus Biopharma free cash flow QuidelOrtho free cash flow

Arbutus Biopharma & QuidelOrtho appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.